Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

During the Trading Day
1.71 +0.07 / +4.27%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
1.82 +0.11 / +6.43%
Volume: 907.00
No recent news for Enzon Pharmaceuticals Inc.

Today’s Trading

Previous close1.64
Today’s open1.82
Day’s range1.66 - 1.83
Average volume (3 months)646,145
Market cap$72.4M
Dividend yield--
Data as of 3:59pm ET, 09/02/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-241.48%
Earnings growth (next 5 years)+53.00%
Revenue growth (last year)-19.03%
P/E ratio2.9


% change
GTXIGTX Inc+0.03+3.16%
APRIApricus Biosciences ...-0.01-0.53%
CPXXCelator Pharmaceutic...-0.12-4.39%
IMMYImprimis Pharmaceuti...+0.11+1.41%
Data as of 3:59pm ET, 09/02/2014


Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$34.5M
Annual profit (last year)$18.2M
Net profit margin52.62%


Health Technology
Chief Executive &
Operating Officer
George W. Hebard
Chief Financial Officer &
Vice President-Finance
Richard L. Feinstein
Corporate headquarters
Piscataway, New Jersey


To view my watchlist

Not a member yet?

Sign up now for a free account

Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.